Summary
The inhibition of monoamine oxidase (MAO) activity by d-amphetamine was measured in homogenates of cat superior cervical ganglion and nictitating membrane, using tyramine (TM) and noradrenaline (NA) as substrates. In both tissues, d-amphetamine was shown to be a competitive inhibitor of the oxidation of TM. The Ki for d-amphetamine, as a MAO inhibitor, was lower in the ganglia than in the peripheral nerve endings.
Similar content being viewed by others
References
H. Blaschko, D. Richter and H. Schlossman, Biochem. J.31, 2187 (1937).
T. J. Mantle, K. F. Tipton and N. J. Garrett, Biochem. Pharmac.25, 2073 (1976).
H. H. Miller and D. E. Clarke, Commun. Psychopharmac.2, 319 (1978).
H. H. Miller, P. A. Shore and D. E. Clarke, Biochem. Pharmac.29, 1347 (1980).
E. J. Filinger and F. J. E. Stefano, Acta physiol. latinoam.31, 105 (1981).
R. E. McCaman, M. W. McCaman, J. M. Hunt and M. S. Smith, J. Neurochem.12, 15 (1965).
F. H. Leitz, F. J. E. Stefano, J. Pharmac. exp. Ther.178, 464 (1971).
O. H. Lowry, N. J. Rosenbrough, A. L. Farr and R. J. Randall, J. biol. Chem.193, 265 (1951).
G. W. Snedecor and G. W. Cochran, in: Statistical methods, 6th edn, p. 549. The Iowas State University Press, 1967.
K. F. Tipton, Biochem. Pharmac.22, 2933 (1973).
Y. Cheng and W. H. Prusoff, Biochem. Pharmac.22, 3099 (1973).
E. J. Filinger and F. J. E. Stefano, Gen. Pharmac.12, 481 (1982).
Author information
Authors and Affiliations
Additional information
Supported by a Contract from the National Research Council of Argentina (CONICET) (Res. 67/79).
Rights and permissions
About this article
Cite this article
Filinger, E.J., Stefano, F.J.E. Monoamine oxidase inhibition by d-amphetamine in ganglia and nerve endings. Experientia 38, 844–845 (1982). https://doi.org/10.1007/BF01972307
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01972307